China Silent Heart Attack Market Size, Share, Impressive Industry Growth, Analysis Report 2028
China silent heart attack market is
estimated to grow considerably at a CAGR of around 7.8% during the forecast
period. Increasing heart attacks in China is projected to offer growth to the
silent heart attack market in China during the forecast period. According to
the World Health Organization (WHO), cardiovascular diseases (CVDs) causes
one-third of the total fatalities each year in China. The medical device market
is one of the fastest-growing markets in China with double-digit growth for
over a decade. In 2018, the medical device market in the country was around
$78.8 billion with an increment of 22% YoY. Hospitals are one of the major
contributors to the market owing to a 70% market share. As of November 2018,
the country has around 32,000 hospitals, out of which more than 12,000 were
public hospitals. As per the Institute for Health Metrics and Evaluation
(IHME), the incidence of CVD is increasing continuously in the country.
Therefore, the presence of such a large number of hospitals with rising CVD
patients is offering growth opportunities to the market players to expand their
presence in China.
To learn more about this report request a sample
copy @ https://www.omrglobal.com/request-sample/china-silent-heart-attack-market
China silent heart attack market is
segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the
market is segmented into an electrocardiography (ECG), chest x-ray, computed
tomography (CT Scan), echocardiography, and others (blood test). Based on
treatment, the market is segmented into medication and surgery. Based on end-user,
the market is segmented into hospitals & clinics and ambulatory surgical
centers (ASCs). Surgery is one of the most commonly required treatments that
increase blood flow. Therefore, angioplasty and bypass surgery are
significantly used for the management of blocked arteries and improve blood
flow to the heart.
The companies which are contributing to
the growth of China silent heart attack market include AstraZeneca PLC, Bayer
AG, Siemens AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim GmbH, Terumo Corp.,
and GlaxoSmithKline Plc. The market players are considerably contributing to
the market growth by the adoption of various strategies including new product
launch, merger, and acquisition, collaborations with government, funding to the
start-ups, and technological advancements to stay competitive in the market.
China Silent Heart Attack Market- Segmentation
By
Diagnosis
·
Electrocardiography (ECG)
·
Magnetic Resonance Imaging (MRI)
·
Computed Tomography (CT Scan)
·
Echocardiography
·
Others (Blood Test)
By
Treatment
·
Medication
·
Surgery
·
By End-User
·
Hospital & Clinics
·
Ambulatory Surgical Centers
A full report of China Silent Heart Attack Market
is available at: https://www.omrglobal.com/industry-reports/china-silent-heart-attack-market
Company Profiles
·
Astellas Pharma,
Inc.
·
AstraZeneca PLC
·
Bayer AG
·
Boehringer
Ingelheim GmbH
·
Boston Scientific
Corp.
·
F. Hoffmann-La
Roche, Ltd.
·
GlaxoSmithKline Plc
·
Medtronic PLC
·
Merck & Co., Inc.
·
Novartis AG
·
Pfizer, Inc.
·
Siemens AG
·
Takeda
Pharmaceutical Co., Ltd.
·
Terumo Corp.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments